Aspect Partners’s Eikon Therapeutics EIKN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.64K Buy
+126
New +$1.29K ﹤0.01% 527

Other funds holding EIKN

Aspect Partners's EIKN Position: Q2 2026 in Review

Aspect Partners opened a new position in Eikon Therapeutics (EIKN) in Q2 2026: 126 shares worth $1.64K. The stake represents ﹤0.01% of the portfolio and ranks #527 among its holdings.

5 funds tracked by Wall St. Rank hold EIKN as of Q2 2026.

  • Aspect Partners held 126 shares of Eikon Therapeutics worth $1.64K as of Q2 2026.
  • Eikon Therapeutics was a new Aspect Partners position in Q2 2026.
  • Eikon Therapeutics made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #527 holding.
  • 5 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.